Facebook Inc (FB)

FB (NASDAQ:Internet) EQUITY
$115.40
pos +0.00
+0.00%
Today's Range: 114.30 - 116.48 | FB Avg Daily Volume: 21,967,600
Last Update: 12/02/16 - 4:00 PM EST
Volume: 0
YTD Performance: 13.15%
Open: $0.00
Previous Close: $115.10
52 Week Range: $89.37 - $133.50
Oustanding Shares: 2,882,167,478
Market Cap: 331,737,476,718
6-Month Chart
TheStreet Ratings Grade for FB
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 24 24 25 24
Moderate Buy 4 4 4 4
Hold 3 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.32 1.27 1.26 1.27
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 44.44
Price Earnings Comparisons:
FB Sector Avg. S&P 500
44.44 44.40 0.00
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-5.90% 10.71% 151.90%
GROWTH 12 Mo 3 Yr CAGR
Revenue 43.80 2.50 0.52
Net Income 25.40 68.60 3.06
EPS 17.30 64.50 2.98
Earnings for FB:
EBITDA 8.17B
Revenue 17.93B
Average Earnings Estimates
Qtr (12/16) Qtr (03/17) FY (12/16) FY (12/17)
Average Estimate $1.09 $0.89 $3.30 $4.36
Number of Analysts 9 5 10 10
High Estimate $1.17 $0.91 $3.42 $4.77
Low Estimate $1.00 $0.86 $3.05 $3.74
Prior Year $0.59 $0.57 $1.49 $3.30
Growth Rate (Year over Year) 84.56% 56.14% 121.74% 31.93%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
RMPIA
By

Eric Jhonsa

 | Dec 2, 2016 | 7:48 PM EST
The social media giant is getting serious about leveraging user data for ad targeting on third-party properties. That opens up some big opportunities.
RMPIA
By

James "Rev Shark" DePorre

 | Dec 2, 2016 | 1:08 PM EST
I'm feeling pressure to force some trades today, but I'm trying to stay selective.
RMPIA
By

Jim Cramer

 | Dec 2, 2016 | 11:06 AM EST
Plus other sectors to watch in this rotation.
RMPIA
By

Christopher Versace

 | Dec 2, 2016 | 9:35 AM EST
And we could see the market give back some November gains on the back of it.
RMPIA
By

James "Rev Shark" DePorre

 | Dec 2, 2016 | 7:01 AM EST
The market is now driving the Fed, rather than the other way around.
RMPIA
By

Bob Byrne

 | Dec 2, 2016 | 7:00 AM EST
Figuring out whether tech stocks are nearing a bottom is no easier.
RMPIA
By

Doug Kass

 | Dec 1, 2016 | 5:48 PM EST
The U.S. dollar weakened. The price of crude oil rallied for a second day in a row, rising $1.50 to almost $51. Gold flat, no bounce. Agricultural commodities: Wheat up $0.07, corn down $0.05, soybean unchanged, oats up $0.05. Lumber up $1. Bonds got schmeissed but traded well off the day's lows (as the 10-year yield touched 2.5%). The 10-year and long-bond yields rose by 9 basis points. The 2s/10s spread rose by another 5 basis points to 130 basis points. Muncipals were lower. Junk bonds got hit badly, despite the rise in crude oil. Blackstone / GSO Strategic Credit Fund (BGB)  rose $0.08. Banks were powerful to the upside. I reshorted at reasonably good prices in the afternoon, after covering my small rental shorts in pre-market trading earlier. Insurance stocks flew. Long Hartford Financial (HIG)  , which rose. Brokerages so strong -- Morgan Stanley (MS) and Goldman Sachs (GS) (up $7). Retail was strong led by Target (TGT) , Foot Locker (FL) , Nike (NKE) and JC Penney (JCP) (long). Autos were the "world's fair." I still have tag end short positions. I expect the upside move to get over-done short term, and I will reload on the short side. Energy stocks up, but small relative to the commodity. Old tech was clobbered. International Business Machines (IBM) , Intel (INTC) , Cisco (CSCO) (short and working nicely) and Microsoft (MSFT) got bashed along with the entire sector. Biotech was down 2%. Allergan (AGN) and Gilead Sciences (GILD) were weak. New lows Vertex Pharmaceuticals (VRX) . Spec weak again (Portula Pharmaceuticals (PTLA) , Sage (SAGE) , Intrexon (XON) , FibroGen (FGEN) , ACADIA Pharmaceuticals (ACAD)  . Big pharma hurtin' badly, once more. Merck (MRK) , Bristol-Myers Squibb (BMY) and Eli Lilly (LLY) being liquidated, much like tech. Media mixed message. Disney (DIS) lower. Ag equipment: Deere (DE) up large on an upgrade, though Caterpillar (CAT) still experiencing weak fundies. Consumer staples broadly lower. Campbell Soup (CPB) excelled on a relative basis, though. (T)FANG a source of funds. Tesla (TSLA) , Facebook (FB) , Amazon (AMZN) and Alphabet (GOOGL) a collective mess. In individual stocks: DuPont (DD) , new high. Radian (RDN) up another up 2%. Oaktree Capital (OAK) not so mighty. Apple hit. Here are some value-added contributions on the site today: 1. Jim "El Capitan" Cramer on " Not What Bulls Wanted to See ."  2. "Meet" Brett Jensen on rotation.  3. Tim "Not Judy or Phil" Collins
RMPIA
By

Jim Cramer

 | Dec 1, 2016 | 2:59 PM EST
You know that money coming in from the sidelines? It's pretty much gone.
RMPIA
By

James "Rev Shark" DePorre

 | Dec 1, 2016 | 11:01 AM EST
Right now, it is more important to protect capital than to build positions.
RMPIA
By

Bob Byrne

 | Dec 1, 2016 | 7:00 AM EST
Selling in bonds and gold continues.

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.